HOME > BUSINESS
BUSINESS
- Ziftomenib Given in New AML Cohort in US PI Trial: Kura/Kyowa Kirin
October 3, 2025
- HIV Support Groups Call for Stronger Mail-In Testing System in Japan
October 3, 2025
- Dayvigo, Jardiance Keep Up Strong Promotion in August: Intage
October 3, 2025
- AbbVie Aims for Neuroscience Leadership, CSO Says in Tokyo
October 2, 2025
- Kyorin Bags Japan Rights to Hinge Bio’s SLE Med
October 2, 2025
- JCR Out-Licenses Fabry Drug to Oman’s Menagen for MENAT Region
October 2, 2025
- Specialist Urges More COVID Shots for Elderly amid “13th Wave”
October 2, 2025
- Sanofi Sets Sights on 2026 NIP Inclusion of RSV Drug Beyfortus in Japan
October 2, 2025
- Teijin, Australian CDMO Form Alliance for Cell and Gene Therapies in Asia-Pacific
October 2, 2025
- Fuji Pharma Seeks Dysmenorrhea Use for Nextstellis in Thailand
October 2, 2025
- Chugai’s PiaSky Now Available in Taiwan for PNH
October 2, 2025
- Takeda to Reevaluate Osaka Plasma Facility Plan as Costs Mount
October 1, 2025
- SSP to Roll Out Pharmacist Training Ahead of OTC Cialis Launch in Japan
October 1, 2025
- Heartseed, Novo Nordisk End Global Cell Therapy Pact
October 1, 2025
- Dalton Drops ASKA Stake Increase Plan, Slams Firm’s “Self-Preservation”
October 1, 2025
- Nxera Earns US$10 Million Milestone from AbbVie in Neurology Deal
October 1, 2025
- Santen, RemeGen Win China Filing Acceptance for RC28-E in DME
October 1, 2025
- Ono Files SK Bio’s Epilepsy Med Cenobamate in Japan
October 1, 2025
- Parexel Exec Says FDA Keeps Reviews on Track amid Staff Cuts, but Notes Leadership Drain
September 30, 2025
- China Approves Monthly IV Maintenance Dosing of Leqembi
September 30, 2025
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
